Does Nox2 induce mitochondrial superoxide production via reverse electron transfer in Angiotensin II-mediated hypertension?
Nox2-induced mitochondrial ROS via reverse electron transfer is identified as a potential new mechanistic target for the pharmacological treatment of hypertension.
These studies show that Nox2 stimulates mitochondrial ROS by activating reverse electron transfer and both mitochondrial O2(•-) and reverse electron transfer may represent new pharmacological targets for the treatment of hypertension.
Dikalov et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: